Compare Under Armour Inc Class A (UA) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Under Armour Inc Class A vs State Street SPDR S&P Biotech ETF — how do they compare? Under Armour Inc Class A trades at $7.18 (market cap $3.07B), while State Street SPDR S&P Biotech ETF trades at $154.43. Which is the better fit depends on your goals.
| UA | XBI | |
|---|---|---|
Market Cap | $3.07B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $7.88 | $164.28 |
52-Week Low | $3.96 | $85.16 |
Enterprise Value | $4.70B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
